{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:45:57Z","timestamp":1795121157791,"version":"4.10.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.eclinm.2024.103037","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:31:01Z","timestamp":1736811061000},"page":"103037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Incidence of cervical intraepithelial neoplasia and cervical cancer in transmasculine and gender diverse individuals using testosterone: a retrospective, single-centre cohort study"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3518-7576","authenticated-orcid":false,"given":"Asra","family":"Vestering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9021-179X","authenticated-orcid":false,"given":"Wouter L.J.","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malou L.H.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3620-5617","authenticated-orcid":false,"given":"Martin den","family":"Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek A.","family":"Groenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.F.","family":"Huirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal M.","family":"Wiepjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah M.","family":"van Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2024.103037_bib1","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/AOG.0000000000004294","article-title":"Health care for transgender and gender diverse individuals: ACOG committee opinion, number 823","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eclinm.2024.103037_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2022.102296","article-title":"Gender-affirming hormonal therapy for transgender and gender-diverse people-A narrative review","volume":"86","author":"Defreyne","year":"2023","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103037_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/medlaw\/fwx028","article-title":"Transgender sterilisation requirements in europe","volume":"25","author":"Dunne","year":"2017","journal-title":"Med Law Rev"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103037_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.21037\/tau.2019.04.09","article-title":"Demographic and temporal trends in transgender identities and gender confirming surgery","volume":"8","author":"Nolan","year":"2019","journal-title":"Transl Androl Urol"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103037_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/dc.25030","article-title":"Cervicovaginal cytology, HPV testing and vaginal flora in transmasculine persons receiving testosterone","volume":"50","author":"Lin","year":"2022","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103037_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/lgbt.2022.0187","article-title":"Pelvic pain in transgender people using testosterone therapy","volume":"10","author":"Zwickl","year":"2023","journal-title":"LGBT Health"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103037_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1557988320925691","article-title":"Bridging barriers to cervical cancer screening in transgender men: a scoping review","volume":"14","author":"Dhillon","year":"2020","journal-title":"Am J Mens Health"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103037_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cyt.12525","article-title":"Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: challenges in detecting dysplasia","volume":"29","author":"Adkins","year":"2018","journal-title":"Cytopathology"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103037_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.amepre.2014.07.031","article-title":"Pap test use is lower among female-to-male patients than non-transgender women","volume":"47","author":"Peitzmeier","year":"2014","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.eclinm.2024.103037_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.path.2022.02.013","article-title":"Reproductive organ pathology of individuals undergoing gender-affirming surgery","volume":"15","author":"Kelley","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.eclinm.2024.103037_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canep.2018.02.008","article-title":"Frequency and distribution of primary site among gender minority cancer patients: an analysis of U.S. National Surveillance Data","volume":"54","author":"Nash","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103037_bib12","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.ejca.2004.03.022","article-title":"Cervical cancer in a female-to-male trans-sexual","volume":"40","author":"Dri\u00e1k","year":"2004","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.eclinm.2024.103037_bib13","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ajog.2010.12.057","article-title":"Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance","volume":"204","author":"Urban","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103037_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","article-title":"Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population","volume":"20","author":"Grynberg","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103037_bib15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ajcp\/aqab158","article-title":"Comparison of cervical cancer screen results on female-to-male transgender patients with female patients","volume":"157","author":"Davis","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.103037_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cncy.22259","article-title":"Cytomorphologic findings of cervical pap smears from female-to-male transgender patients on testosterone therapy","volume":"128","author":"Williams","year":"2020","journal-title":"Cancer Cytopathol"},{"issue":"13","key":"10.1016\/j.eclinm.2024.103037_bib17","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":"Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103037_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1186\/s12885-022-10179-1","article-title":"Spontaneous regression of cervical intraepithelial neoplasia 3 in women with a biopsy\u2014cone interval of greater than 11 weeks","volume":"22","author":"Bruno","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eclinm.2024.103037_bib19","article-title":"Pathology Databanking and Biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data Network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"issue":"7624","key":"10.1016\/j.eclinm.2024.103037_bib20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103037_bib21","first-page":"582","article-title":"The Amsterdam cohort of gender dysphoria study (1972-2015): trends in prevalence, treatment, and regrets","volume":"15","author":"Wiepjes","year":"2018","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103037_bib22","first-page":"327","article-title":"Association of serum concentrations of testosterone and insulin with the degree of cervical squamous intraepithelial lesions in Cuban women","volume":"4","author":"Frontela-Noda","year":"2022","journal-title":"J\u00a0Cervical Cancer Res"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103037_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147029","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.eclinm.2024.103037_bib24","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.3390\/ijms23095050","article-title":"Like brothers in arms: how hormonal stimuli and changes in the metabolism signaling cooperate, leading HPV infection to drive the onset of cervical cancer","volume":"23","author":"L\u00e4sche","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103037_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12916-019-1460-0","article-title":"Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study","volume":"17","author":"Aitken","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.eclinm.2024.103037_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101702","article-title":"HPV screening in the urine of transpeople - a prevalence study","volume":"54","author":"Pils","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103037_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103037_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12985-020-01420-z","article-title":"Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+","volume":"17","author":"Berggrund","year":"2020","journal-title":"Virol J"},{"issue":"709","key":"10.1016\/j.eclinm.2024.103037_bib29","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.3399\/BJGP.2020.0905","article-title":"Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK","volume":"71","author":"Berner","year":"2021","journal-title":"Br J Gen Pract"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103037_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/LGT.0000000000000763","article-title":"Understanding sexual and gender minority populations and organ-based screening recommendations for human papillomavirus-related cancers","volume":"27","author":"Jodry","year":"2023","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103037_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation","volume":"116","author":"Palmer","year":"2024","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.eclinm.2024.103037_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/lgbt.2016.0142","article-title":"Human papillomavirus-related cancer surveillance, prevention, and screening among transgender men and women: neglected populations at high risk","volume":"4","author":"Brown","year":"2017","journal-title":"LGBT Health"},{"issue":"12","key":"10.1016\/j.eclinm.2024.103037_bib33","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.eprac.2024.09.007","article-title":"Continuation of gender-affirming hormone therapy in transgender and gender-diverse individuals: a systematic review","volume":"30","author":"Gupta","year":"2024","journal-title":"Endocr Pract"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024006163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024006163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:08:26Z","timestamp":1740384506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024006163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"alternative-id":["S2589537024006163"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.103037","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of cervical intraepithelial neoplasia and cervical cancer in transmasculine and gender diverse individuals using testosterone: a retrospective, single-centre cohort study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.103037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103037"}}